FINDING, DEVELOPMENT AND ACQUISITION COSTS - CARDIUM PROPERTIES ONLY
Year Ended December 31, 2012
Finding, Finding, Development Change in Development & Future Net & Acquisition Development Total Additions Acquisition Costs Costs Costs (1) Costs (in thousands of dollars) (MBOE)(2) ($/BOE) ----------------------------------------------------------2012 Proved $ 14,090 $ (13,330) $ 760 659 $ 1.152012 P&P 14,090 (11,130) 2,960 949 3.122011 Proved 162,700 34,830 197,530 5,044 39.162011 P&P 162,700 77,370 240,070 8,997 26.683 year average proved 235,420 58,350 293,770 7,989 36.773 year average P&P $ 235,420 $ 129,740 $ 365,160 14,146 $ 25.81(1) Net Additions are defined as the sum of reserve additions, revisions, and acquisitions less dispositions.(2) Barrels of oil equivalent ("BOE") may be misleading, particularly if used in isolation. A BOE conversion ratio of 6 Mcf: 1 bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead.FD&A costs on a total company basis were indeterminate in 2012, as the Company's proceeds from selling assets exceeded its field capital program expenditures. The Company believes that finding and development costs should include acquisition and disposition costs as these functions are not segregated operationally in the Company, and it is a useful and commonly used reference for shareholders and analysts. In the Cardium play, full cycle three year average FD&A costs including future development capital were $36.77 per BOE on a TP basis and $25.81 per BOE on a P&P basis. This compares to 2012 one year FD&A costs of $1.15 per BOE on a TP basis and $3.12 per BOE on a P&P basis and 2011 one year FD&A costs of $39.16 per BOE on a TP basis and $26.68 per BOE on a P&P basis. The aggregate of the exploration, development and acquisition costs incurred in the most recent financial year and the change during the year in estimated future development costs generally will not reflect total FD&A costs related to reserve additions for that year.
SHARE INFORMATION
The Company's shares have been listed on the Toronto Stock Exchange since September 7, 2005 under the symbol "AXL". As of March 15, 2013, there were 172.5 million common shares outstanding, 14.3 million stock options outstanding, $50.0 million principal amount of convertible debentures which are convertible into common shares at a conversion price of $1.55 per common share and $46.0 million principal amount of convertible debentures which are convertible into common shares at a conversion price of $1.70 per common share. During 2012, no common shares (2011 - 64,400) were issued under the employee stock option plan.
SHARE PRICE ON TSX
2012 2011High $ 0.68 $ 1.36Low $ 0.21 $ 0.35Close $ 0.24 $ 0.54Volume 45,207,571 141,911,562Shares outstanding at December 31 172,549,701 172,549,701Market capitalization at December 31 $ 40,549,180 $ 93,176,839----------------------------------------------------------------------------



